News Release

Are most ORR electrocatalysts promising nanocatalytic medicines for tumor therapy?

Peer-Reviewed Publication

Science China Press

Schematic diagram of the bridging between oxidase catalysis and ORR electrocatalysis

image: On the left is the velocity (v) of the TMB chromogenic reaction in water. In the center is the LSV curves of various samples in O2-saturated deionized water. On the right is the linear fitting between the nondimensionalized velocity (vn) of the chromogenic reaction at varied TMB concentrations and the absolute value of the normalized mean current density from 1 to 0 V in the ORR. view more 

Credit: ©Science China Press

The current searches for medical catalysts mainly rely on trial-and-error protocols, due to the lack of theoretical guidance. Thus, it is of great significance to establish a rapid experimental evaluation protocol for screening catalysts in addition to the possible theoretical predictions by computation. This study is led by Prof. Jianlin Shi (Shanghai Institute of Ceramics, Chinese Academy of Sciences), and his group proposes that oxidase catalysis and oxygen reduction reaction (ORR) electrocatalysis share the identical activity origin using model single-atom catalysts (SACs), and a facile electrochemical methodology (linear sweep voltammetry) has been developed for oxidase-like activity evaluation.

The researchers chose a series of comparable SACs of relatively uniform active site as model catalysts. The nondimensionalized velocity (vn) of the TMB chromogenic reaction and the absolute value of the normalized mean current density in the LSV curves quantitatively show a good linear relationship with each other (image below), indicating the intrinsic homology between oxidase catalysis and electrocatalysis and the feasibility of electrochemical methodologies for characterizing oxidase activity. In addition, the LSV technique features a larger generality of tests than chromogenic reaction, even in simulated body fluid and DMEM. More interestingly, the cancer cell killing effects of SACs also reasonably follows the order of ORR activities. People have developed tens of thousands of catalysts for oxygen reduction electrocatalysis, this work proves that these oxygen reduction electrocatalysts are the promising candidates for oxidase mimics and therefore could be used in nanomedicine fields, such as tumor therapy and antibacterial.

"Although enzymatic catalysis and electrocatalysis are generally considered as two independent scientific fields, this study bridges oxidase catalysis and ORR electrocatalysis, which will strongly promote the subsequent exploration of the relationship between enzymatic catalysis and electrocatalysis," the paper claims.


See the article:

Bridging Oxidase Catalysis and Oxygen Reduction Electrocatalysis by Model Single-Atom Catalysts

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.